Lab
Surviving Our Losses and Continuing Everyday, INC.
Surviving Our Losses and Continuing Everyday, INC. was paid $6.52M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is H0015, Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education — 32% of everything it billed.
33Billing provider infoSURVIVING OUR LOSSES AND CONTINUING EVERYDAY, INC.
PORTSMOUTH, OH 45662
PORTSMOUTH, OH 45662
33aNPI1508253493assigned 04/19/2015
33bProvider typeClinical Medical Laboratory
28Total paid$6.52M
24GClaims160,321
24DCodes billed49
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Ohio
Rank by total paid#21 of 116
Median peer was paid$313K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,425 | $932K | |
| 2019 | 27,675 | $700K | |
| 2020 | 33,532 | $738K | |
| 2021 | 14,368 | $706K | |
| 2022 | 17,745 | $959K | |
| 2023 | 15,996 | $1.07M | |
| 2024incomplete | 17,580 | $1.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 32% | 13,369 | 4,412 | $2.11M |
| H0006 | Alcohol and/or drug services; case management | 16% | 25,427 | 10,130 | $1.03M |
| H0038 | Self-help/peer services, per 15 minutes | 10% | 11,990 | 2,914 | $674K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 8.9% | 41,399 | 11,386 | $580K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 5.8% | 10,766 | 3,654 | $380K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 5.7% | 3,853 | 1,913 | $372K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.4% | 6,088 | 2,840 | $290K |
| T1003 | Lpn/lvn services, up to 15 minutes | 2.6% | 7,011 | 3,932 | $168K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 2.4% | 2,329 | 1,517 | $154K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 3,486 | 3,257 | $152K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.1% | 2,710 | 1,709 | $139K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.2% | 3,755 | 1,883 | $78K |
37 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 399 | $41K |
| 80361 | <1% | 1,715 | $28K | |
| 80346 | <1% | 1,409 | $27K | |
| 80363 | <1% | 1,405 | $23K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 230 | $22K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 262 | $21K |
| 80348 | <1% | 1,866 | $16K | |
| 80354 | <1% | 1,829 | $16K | |
| 80355 | <1% | 1,731 | $15K | |
| 80365 | <1% | 1,713 | $15K | |
| 80358 | <1% | 1,711 | $15K | |
| 80373 | <1% | 1,712 | $15K | |
| 80366 | <1% | 1,712 | $15K | |
| 80349 | <1% | 1,623 | $15K | |
| 80360 | <1% | 1,578 | $15K | |
| T1002 | Rn services, up to 15 minutes | <1% | 392 | $14K |
| 80356 | <1% | 1,366 | $13K | |
| 80372 | <1% | 1,407 | $13K | |
| 80362 | <1% | 361 | $6K | |
| 80347 | <1% | 269 | $5K | |
| 90785 | <1% | 446 | $5K | |
| 83992 | <1% | 261 | $3K | |
| 80325 | <1% | 268 | $3K | |
| 80369 | <1% | 268 | $3K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 20 | $2K |
| 80353 | <1% | 269 | $2K | |
| 80324 | <1% | 267 | $2K | |
| 80345 | <1% | 261 | $2K | |
| 80359 | <1% | 261 | $2K | |
| 80336 | <1% | 261 | $2K | |
| 80368 | <1% | 261 | $2K | |
| 80370 | <1% | 260 | $2K | |
| 82075 | <1% | 96 | $1K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 44 | $865.20 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $846.70 |
| 80323 | <1% | 82 | $570.18 | |
| 90875 | 0% | 109 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRAULINI, MICHAEL (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Surviving Our Losses and Continuing Everyday, INC. | Portsmouth, OH | $60K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.